Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea, Obstructive | 20 | 2026 | 229 | 5.750 |
Why?
|
| Sleep | 24 | 2025 | 465 | 4.050 |
Why?
|
| Continuous Positive Airway Pressure | 7 | 2025 | 56 | 2.070 |
Why?
|
| Sleep Deprivation | 10 | 2017 | 128 | 1.510 |
Why?
|
| Blood Glucose | 14 | 2026 | 914 | 1.490 |
Why?
|
| Obesity | 14 | 2025 | 1077 | 1.440 |
Why?
|
| Diabetes Mellitus, Type 2 | 11 | 2026 | 1290 | 1.380 |
Why?
|
| Insulin Resistance | 13 | 2016 | 391 | 1.380 |
Why?
|
| Prediabetic State | 3 | 2020 | 43 | 1.150 |
Why?
|
| Sleep Wake Disorders | 6 | 2025 | 139 | 1.150 |
Why?
|
| Sleep Medicine Specialty | 4 | 2015 | 9 | 1.140 |
Why?
|
| Glucose | 4 | 2023 | 704 | 1.090 |
Why?
|
| Circadian Rhythm | 6 | 2025 | 295 | 1.090 |
Why?
|
| Overweight | 2 | 2022 | 128 | 1.050 |
Why?
|
| Consensus | 4 | 2015 | 309 | 0.930 |
Why?
|
| Health | 3 | 2015 | 27 | 0.920 |
Why?
|
| Energy Intake | 3 | 2022 | 100 | 0.910 |
Why?
|
| Ghrelin | 4 | 2015 | 31 | 0.910 |
Why?
|
| Eating | 3 | 2016 | 164 | 0.860 |
Why?
|
| Heart Rate | 3 | 2026 | 534 | 0.780 |
Why?
|
| Weight Loss | 2 | 2022 | 245 | 0.740 |
Why?
|
| Polysomnography | 11 | 2021 | 154 | 0.730 |
Why?
|
| Polycystic Ovary Syndrome | 3 | 2010 | 196 | 0.710 |
Why?
|
| Diet, Mediterranean | 1 | 2022 | 6 | 0.710 |
Why?
|
| Academies and Institutes | 4 | 2015 | 35 | 0.700 |
Why?
|
| Rest | 1 | 2020 | 52 | 0.640 |
Why?
|
| Cardiovascular Diseases | 4 | 2025 | 822 | 0.610 |
Why?
|
| Hypertension | 1 | 2025 | 788 | 0.590 |
Why?
|
| Telemedicine | 1 | 2022 | 253 | 0.580 |
Why?
|
| Insulin | 7 | 2021 | 1224 | 0.570 |
Why?
|
| Diabetes Mellitus | 2 | 2025 | 813 | 0.550 |
Why?
|
| Glycerides | 2 | 2016 | 14 | 0.550 |
Why?
|
| Arachidonic Acids | 2 | 2016 | 37 | 0.550 |
Why?
|
| Endocannabinoids | 2 | 2016 | 28 | 0.540 |
Why?
|
| Humans | 53 | 2026 | 98362 | 0.510 |
Why?
|
| Diet | 4 | 2025 | 469 | 0.510 |
Why?
|
| Vegetables | 3 | 2025 | 50 | 0.500 |
Why?
|
| Adult | 29 | 2026 | 29587 | 0.490 |
Why?
|
| Young Adult | 15 | 2026 | 7568 | 0.470 |
Why?
|
| Risk Factors | 15 | 2026 | 6271 | 0.450 |
Why?
|
| Societies, Scientific | 1 | 2015 | 40 | 0.440 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2015 | 67 | 0.440 |
Why?
|
| Patient Compliance | 3 | 2022 | 245 | 0.380 |
Why?
|
| Thinness | 1 | 2012 | 49 | 0.360 |
Why?
|
| Glucose Intolerance | 2 | 2010 | 101 | 0.340 |
Why?
|
| Motivation | 1 | 2014 | 344 | 0.330 |
Why?
|
| Male | 26 | 2026 | 47257 | 0.330 |
Why?
|
| Body Mass Index | 4 | 2022 | 867 | 0.320 |
Why?
|
| Fruit | 2 | 2025 | 82 | 0.320 |
Why?
|
| Research | 3 | 2015 | 257 | 0.310 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2026 | 54 | 0.290 |
Why?
|
| Female | 24 | 2026 | 51756 | 0.290 |
Why?
|
| Metabolic Syndrome | 2 | 2008 | 126 | 0.290 |
Why?
|
| Sleep Stages | 2 | 2008 | 45 | 0.280 |
Why?
|
| Dietary Fats | 2 | 2022 | 135 | 0.280 |
Why?
|
| Appetite | 3 | 2015 | 21 | 0.270 |
Why?
|
| Leptin | 3 | 2015 | 102 | 0.270 |
Why?
|
| Time Factors | 6 | 2015 | 5576 | 0.270 |
Why?
|
| Hydrocortisone | 5 | 2017 | 305 | 0.260 |
Why?
|
| Dietary Carbohydrates | 2 | 2022 | 39 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2025 | 686 | 0.260 |
Why?
|
| Pituitary-Adrenal System | 3 | 2017 | 69 | 0.240 |
Why?
|
| Dietary Proteins | 2 | 2017 | 31 | 0.230 |
Why?
|
| Actigraphy | 3 | 2025 | 69 | 0.230 |
Why?
|
| Adolescent | 8 | 2021 | 10137 | 0.220 |
Why?
|
| Respiratory Mechanics | 1 | 2005 | 109 | 0.220 |
Why?
|
| Women's Health | 1 | 2026 | 120 | 0.210 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2024 | 44 | 0.210 |
Why?
|
| Blood Pressure Determination | 1 | 2024 | 73 | 0.210 |
Why?
|
| Energy Metabolism | 4 | 2017 | 314 | 0.210 |
Why?
|
| Wearable Electronic Devices | 1 | 2024 | 45 | 0.200 |
Why?
|
| Middle Aged | 13 | 2026 | 29532 | 0.200 |
Why?
|
| Sleep Disorders, Intrinsic | 1 | 2023 | 5 | 0.190 |
Why?
|
| Human Growth Hormone | 3 | 2015 | 51 | 0.180 |
Why?
|
| Glucose Tolerance Test | 4 | 2017 | 239 | 0.180 |
Why?
|
| Dietary Fiber | 1 | 2022 | 47 | 0.170 |
Why?
|
| United States | 6 | 2026 | 8258 | 0.170 |
Why?
|
| Disease Outbreaks | 1 | 2002 | 149 | 0.170 |
Why?
|
| Healthy Volunteers | 3 | 2017 | 154 | 0.160 |
Why?
|
| Proof of Concept Study | 1 | 2020 | 64 | 0.160 |
Why?
|
| Blood Pressure | 1 | 2024 | 920 | 0.160 |
Why?
|
| Biomedical Research | 1 | 2025 | 471 | 0.160 |
Why?
|
| Biomarkers | 3 | 2015 | 2021 | 0.150 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 265 | 0.140 |
Why?
|
| Random Allocation | 2 | 2017 | 312 | 0.140 |
Why?
|
| Area Under Curve | 2 | 2010 | 340 | 0.130 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2017 | 40 | 0.130 |
Why?
|
| Electroencephalography | 4 | 2017 | 799 | 0.120 |
Why?
|
| Enterocytes | 1 | 2016 | 29 | 0.120 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2014 | 83 | 0.120 |
Why?
|
| Hyperphagia | 1 | 2016 | 36 | 0.120 |
Why?
|
| Body Weight | 1 | 2017 | 456 | 0.120 |
Why?
|
| Prospective Studies | 3 | 2026 | 4817 | 0.120 |
Why?
|
| Intestinal Absorption | 1 | 2016 | 125 | 0.110 |
Why?
|
| Postprandial Period | 2 | 2016 | 44 | 0.110 |
Why?
|
| Fasting | 2 | 2016 | 166 | 0.110 |
Why?
|
| Norepinephrine | 1 | 2015 | 166 | 0.110 |
Why?
|
| Food, Organic | 1 | 2014 | 3 | 0.110 |
Why?
|
| Food Preferences | 1 | 2014 | 28 | 0.100 |
Why?
|
| Cross-Over Studies | 4 | 2017 | 394 | 0.100 |
Why?
|
| Aged | 7 | 2026 | 21844 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 440 | 0.100 |
Why?
|
| Health Promotion | 1 | 2015 | 175 | 0.100 |
Why?
|
| Animals | 5 | 2025 | 28981 | 0.100 |
Why?
|
| Health Status | 2 | 2005 | 388 | 0.100 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 4044 | 0.100 |
Why?
|
| ROC Curve | 1 | 2015 | 793 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2016 | 489 | 0.090 |
Why?
|
| Choice Behavior | 1 | 2014 | 164 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2015 | 743 | 0.090 |
Why?
|
| Comorbidity | 2 | 2008 | 1035 | 0.080 |
Why?
|
| Adipocytes | 1 | 2012 | 180 | 0.080 |
Why?
|
| Societies, Medical | 1 | 2015 | 687 | 0.080 |
Why?
|
| Hunger | 2 | 2016 | 22 | 0.080 |
Why?
|
| Acylation | 1 | 2010 | 66 | 0.080 |
Why?
|
| Autonomic Nervous System | 1 | 2010 | 70 | 0.080 |
Why?
|
| Hormones | 1 | 2010 | 138 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2017 | 2009 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2009 | 187 | 0.070 |
Why?
|
| Snoring | 1 | 2008 | 12 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2010 | 528 | 0.070 |
Why?
|
| Arousal | 1 | 2008 | 177 | 0.060 |
Why?
|
| Neurosecretory Systems | 1 | 2007 | 36 | 0.060 |
Why?
|
| Brain | 1 | 2017 | 2439 | 0.060 |
Why?
|
| Hemodynamics | 1 | 2010 | 746 | 0.060 |
Why?
|
| Dietary Approaches To Stop Hypertension | 1 | 2026 | 1 | 0.060 |
Why?
|
| Delta Rhythm | 1 | 2005 | 18 | 0.060 |
Why?
|
| Prolactin | 1 | 2005 | 90 | 0.060 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2017 | 125 | 0.060 |
Why?
|
| Postmenopause | 1 | 2026 | 109 | 0.060 |
Why?
|
| Blood Pressure Monitors | 1 | 2024 | 10 | 0.050 |
Why?
|
| Peptide Hormones | 1 | 2004 | 30 | 0.050 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2005 | 109 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 2017 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 7418 | 0.050 |
Why?
|
| Equipment Design | 1 | 2024 | 425 | 0.050 |
Why?
|
| Self Report | 1 | 2025 | 357 | 0.050 |
Why?
|
| Glucokinase | 1 | 2023 | 61 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2023 | 81 | 0.050 |
Why?
|
| Hypoxia | 1 | 2008 | 682 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2024 | 720 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2026 | 1296 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2015 | 9770 | 0.040 |
Why?
|
| Behcet Syndrome | 1 | 2001 | 15 | 0.040 |
Why?
|
| Inflammation | 1 | 2008 | 1133 | 0.040 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2021 | 75 | 0.040 |
Why?
|
| Insulin Infusion Systems | 1 | 2021 | 59 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2001 | 284 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 2792 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2005 | 3227 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 416 | 0.030 |
Why?
|
| Adiposity | 1 | 2017 | 81 | 0.030 |
Why?
|
| Sheep | 1 | 2017 | 204 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2005 | 3032 | 0.030 |
Why?
|
| Body Composition | 1 | 2017 | 88 | 0.030 |
Why?
|
| Appetite Regulation | 1 | 2016 | 7 | 0.030 |
Why?
|
| Pedigree | 1 | 2017 | 987 | 0.030 |
Why?
|
| Wakefulness | 1 | 2016 | 127 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2016 | 123 | 0.030 |
Why?
|
| Risk | 1 | 2016 | 660 | 0.030 |
Why?
|
| Child | 1 | 2025 | 7745 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2017 | 384 | 0.020 |
Why?
|
| Reward | 1 | 2016 | 228 | 0.020 |
Why?
|
| Sex Factors | 2 | 2005 | 1142 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 370 | 0.020 |
Why?
|
| Mutation | 1 | 2023 | 4428 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 2008 | 31 | 0.020 |
Why?
|
| Sleep, REM | 1 | 2008 | 49 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1947 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 2577 | 0.020 |
Why?
|
| Glucaric Acid | 1 | 2005 | 5 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 2005 | 46 | 0.010 |
Why?
|
| Alpha Rhythm | 1 | 2005 | 28 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 2005 | 100 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 3633 | 0.010 |
Why?
|
| Hemoptysis | 1 | 2001 | 27 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 2001 | 92 | 0.010 |
Why?
|
| Aneurysm | 1 | 2001 | 58 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2001 | 342 | 0.010 |
Why?
|
| Thrombolytic Therapy | 1 | 2001 | 261 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2001 | 826 | 0.010 |
Why?
|
| Prognosis | 1 | 2001 | 4126 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2001 | 2678 | 0.010 |
Why?
|